AT1.AX

Healthcare Medical Devices

Atomo Diagnostics Limited

A$0.02

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

16.24M

Avg Volume

756,515

52W High

A$0.05

52W Low

A$0.02

Div. Yield

0.0%

Valuation

Forward P/E

-0.02

P/B Ratio

2.00

P/S Ratio

3.05

EV/EBITDA

-3.16

EV/Revenue

2.42

Margins

Gross Margin 33.1%

Operating Margin (82.1%)

Net Margin (65.9%)

EBITDA Margin (76.6%)

Growth & Returns

Revenue Growth (YoY)

81.2%

Return on Equity

(47.9%)

Return on Assets

(31.2%)

Liquidity & Leverage

Current Ratio

3.04

Quick Ratio

2.37

Debt / Equity

0.05

Total Cash

3.71M

Total Debt

373,082

About

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

atomodiagnostics.com